Q-linea AB (publ) (QLINEA.ST)

SEK 0.04

(-1.92%)

Total Liabilities Summary of Q-linea AB (publ)

  • Q-linea AB (publ)'s latest annual total liabilities in 2023 was 42.34 Million SEK , down -7.47% from previous year.
  • Q-linea AB (publ)'s latest quarterly total liabilities in 2024 Q2 was 90.86 Million SEK , up 125.77% from previous quarter.
  • Q-linea AB (publ) reported annual total liabilities of 45.75 Million SEK in 2022, up 27.65% from previous year.
  • Q-linea AB (publ) reported annual total liabilities of 35.84 Million SEK in 2021, up 11.89% from previous year.
  • Q-linea AB (publ) reported quarterly total liabilities of 40.24 Million SEK for 2024 Q1, down -4.94% from previous quarter.
  • Q-linea AB (publ) reported quarterly total liabilities of 85.78 Million SEK for 2023 Q1, up 87.47% from previous quarter.

Annual Total Liabilities Chart of Q-linea AB (publ) (2023 - 2015)

Historical Annual Total Liabilities of Q-linea AB (publ) (2023 - 2015)

Year Total Liabilities Total Liabilities Growth
2023 42.34 Million SEK -7.47%
2022 45.75 Million SEK 27.65%
2021 35.84 Million SEK 11.89%
2020 32.03 Million SEK -4.26%
2019 33.46 Million SEK 30.66%
2018 25.61 Million SEK 51.67%
2017 16.88 Million SEK 100.84%
2016 8.4 Million SEK 51.37%
2015 5.55 Million SEK 0.0%

Peer Total Liabilities Comparison of Q-linea AB (publ)

Name Total Liabilities Total Liabilities Difference
AddLife AB (publ) 7.78 Billion SEK 99.456%
Biotage AB (publ) 1.27 Billion SEK 96.677%
Bonesupport Holding AB (publ) 143.63 Million SEK 70.523%
Doxa AB (publ) 280.8 Million SEK 84.922%
Elekta AB (publ) 21.61 Billion SEK 99.804%
iZafe Group AB (publ) 9.26 Million SEK -357.186%
Ortivus AB (publ) 55.4 Million SEK 23.575%
Ortivus AB (publ) 55.4 Million SEK 23.575%
S2Medical AB (publ) 19.74 Million SEK -114.386%
Synsam AB (publ) 5.52 Billion SEK 99.233%